Overview

Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate bioequivalence between tacrobell capsule 1mg and prograf capsule 1mg.
Phase:
N/A
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Tacrolimus